Saturday, July, 20, 2019 05:05:12

Category: Health

Eurofins to offer Synthego’s CRISPR technology to global clients

Eurofins Genomics, a global leader in bioanalytical testing has recently announced plans to collaborate with leading genome engineering products provider Synthego, to distribute sgRNA (synthetic single guide RNA) to the company’s global customer database across 44 countries. CRISPR technology is being accepted by clinical labs …

AstraZeneca inks deal with Sobi to sell the US rights for Synagis®

AstraZeneca, the pharmaceutical firm headquartered in Cambridge, has confirmed the sale of the U.S. rights to Synagis®, which is used for preventing respiratory tract infections, to specialty biopharmaceutical company Sobi AB. The multibillion-dollar deal would also involve nearly 130 workers being transferred to the Swedish …

Merck rolls out BioContinuum platform to advance drug manufacturing

U.S. based pharmaceutical company Merck has reportedly launched its BioContinuum Platform in an attempt to advance the production of biotherapeutic drugs through improved efficiency, greater quality and consistency as well as simplified plant operations. This expanded offering was introduced by the company at the 2018 …

U.S. FDA approves Pfizer Inc’s lung cancer medicine LORBRENA®

Pfizer Inc., the New York-based pharmaceutical company, has reportedly announced that its third-generation lung cancer drug LORBRENA has been approved by the U.S. Food & Drug Administration (FDA). Reports cite, the drug – an ALK TKI (Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor) – is designed …